Data Show Vectra DA is Better Predictor of Joint Damage in RA Patients
SALT LAKE CITY, Nov. 19, 2014 -- (Healthcare Sales & Marketing Network) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (MYGN), today presented new data t...
Diagnostics
Myriad Genetics, Crescendo Bioscience, Vectra DA, rheumatoid arthritis